搜索
Radiopharm Theranostics Ltd
RADX添加自选
3.080USD
-0.120-3.75%
收盘 07-31 16:00（美东）报价延迟15分钟
0.00总市值
--市盈率 TTM
关于 Radiopharm Theranostics Ltd 公司
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.
Radiopharm Theranostics Ltd简介
公司代码RADX
公司名称Radiopharm Theranostics Ltd
上市日期Nov 25, 2021
CEOCanevari (Riccardo)
员工数量- -
证券类型Depository Receipt
年结日- -
公司地址Level 3, 62 Lygon Street
城市MELBOURNE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Australia
邮编3053
电话61398245254
网址https://radiopharmtheranostics.com/
公司代码RADX
上市日期Nov 25, 2021
CEOCanevari (Riccardo)
Radiopharm Theranostics Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Riccardo Canevari
Mr. Riccardo Canevari
Chief Executive Officer, Managing Director
Chief Executive Officer, Managing Director
--
--
Mr. Paul Hopper
Mr. Paul Hopper
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Thomas H. (Thom) Tulip, Ph.D.
Dr. Thomas H. (Thom) Tulip, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Dr. Dimitris Voliotis, M.D.
Dr. Dimitris Voliotis, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Hester Larkin
Ms. Hester Larkin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ian Turner
Mr. Ian Turner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phillip Hains
Mr. Phillip Hains
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Noel P. Donnelly
Mr. Noel P. Donnelly
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Bruce Goodwin
Mr. Bruce Goodwin
Non-Executive Director
Non-Executive Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Riccardo Canevari
Mr. Riccardo Canevari
Chief Executive Officer, Managing Director
Chief Executive Officer, Managing Director
--
--
Mr. Paul Hopper
Mr. Paul Hopper
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Thomas H. (Thom) Tulip, Ph.D.
Dr. Thomas H. (Thom) Tulip, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Dr. Dimitris Voliotis, M.D.
Dr. Dimitris Voliotis, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Hester Larkin
Ms. Hester Larkin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ian Turner
Mr. Ian Turner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
常见问题
Radiopharm Theranostics Ltd的前五大股东是谁？
Radiopharm Theranostics Ltd 的前五大股东如下：Mr. Riccardo Canevari
有多少机构持有Radiopharm Theranostics Ltd(RADX)的股份？
截至2026Q1，共有11家机构持有Radiopharm Theranostics Ltd的股份，合计持有的股份价值约为51.39M，占公司总股份的3.30%。与2025Q4相比，机构持股有所增加，增幅为50862187.00。